论文部分内容阅读
上海医科大学最近研制成功的注射用重组链激酶(Y—SK),日前通过临床一期使用,开创了我国基因工程药物临床使用的先河。
Shanghai Medical University recently developed recombinant streptokinase for injection (Y-SK), recently through a clinical use, creating a clinical application of genetic engineering drugs in China precedent.